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Flotillin-dependent clustering of the amyloid precursor
protein regulates its endocytosis and amyloidogenic
processing in neurons
Abstract
The flotillins/reggie proteins are associated with noncaveolar membrane microdomains and
have been implicated in the regulation of a clathrin- and caveolin-independent endocytosis
pathway. Endocytosis is required for the amyloidogenic processing of the amyloid precursor
protein (APP) and thus to initiate the release of the neurotoxic beta-amyloid peptide (Abeta),
the major component of extracellular plaques found in the brains of Alzheimer's disease
patients. Here, we report that small interference RNA-mediated downregulation of flotillin-2
impairs the endocytosis of APP, in both neuroblastoma cells and primary cultures of
hippocampal neurons, and reduces the production of Abeta. Similar to tetanus neurotoxin
endocytosis, but unlike the internalization of transferrin, clathrin-dependent endocytosis of
APP requires cholesterol and adaptor protein-2 but is independent of epsin1 function.
Moreover, on a nanoscale resolution using stimulated emission depletion microscopy and by
Förster resonance energy transfer with fluorescence lifetime imaging microscopy, we provide
evidence that flotillin-2 promotes the clustering of APP at the cell surface. We show that the
interaction of flotillin-2 with APP is dependent on cholesterol and that clustering of APP
enhances its endocytosis rate. Together, our data suggest that cholesterol/flotillin-dependent
clustering of APP may stimulate the internalization into a specialized clathrin-dependent
endocytosis pathway to promote amyloidogenic processing.
Neurobiology of Disease
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The flotillins/reggie proteins are associated with noncaveolar membranemicrodomains and have been implicated in the regulation of a
clathrin- and caveolin-independent endocytosis pathway. Endocytosis is required for the amyloidogenic processing of the amyloid
precursor protein (APP) and thus to initiate the release of the neurotoxic-amyloid peptide (A), themajor component of extracellular
plaques found in the brains of Alzheimer’s disease patients. Here, we report that small interference RNA-mediated downregulation of
flotillin-2 impairs the endocytosis of APP, in both neuroblastoma cells and primary cultures of hippocampal neurons, and reduces the
production of A. Similar to tetanus neurotoxin endocytosis, but unlike the internalization of transferrin, clathrin-dependent endocy-
tosis of APP requires cholesterol and adaptor protein-2 but is independent of epsin1 function.Moreover, on a nanoscale resolution using
stimulated emission depletionmicroscopy and by Fo¨rster resonance energy transfer with fluorescence lifetime imagingmicroscopy, we
provide evidence that flotillin-2 promotes the clustering of APP at the cell surface. We show that the interaction of flotillin-2 with APP is
dependent on cholesterol and that clustering of APP enhances its endocytosis rate. Together, our data suggest that cholesterol/flotillin-
dependent clustering of APP may stimulate the internalization into a specialized clathrin-dependent endocytosis pathway to promote
amyloidogenic processing.
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Introduction
Flotillin-1/reggie-2 and flotillin-2/reggie-1 are two highly con-
served proteins associated with lipid rafts that have been impli-
cated in a wide range of cellular processes such as axonal regen-
eration, insulin signaling, and recently also in endocytosis
(Langhorst et al., 2005). Flotillins are palmitoylated and myris-
toylated proteins that are anchored to the cytoplasmicmembrane
bilayer, in which they form multimeric scaffolds (Morrow et al.,
2002; Neumann-Giesen et al., 2004; Frick et al., 2007; Solis et al.,
2007). Expression of flotillin is particular high in cells that lack
caveolin, e.g., lymphocytes and neurons (Lang et al., 1998; Rajen-
dran et al., 2003), and an accumulation of flotillin was found in
the endosomal system of neurons from amyloid precursor pro-
teinpresenilin 1 (APPPS1) transgenicmice and patientswith
Alzheimer’s disease (AD) (Girardot et al., 2003; Langui et al.,
2004). An additional link between flotillin and AD is the associ-
ation of flotillin with cholesterol-rich detergent resistant mem-
branes, which have been implicated in the generation of the
-amyloid peptide (A) (Kojro et al., 2001; Riddell et al., 2001;
Cordy et al., 2003; Ehehalt et al., 2003; Puglielli et al., 2003;
Vetrivel et al., 2004; Kalvodova et al., 2005).
A is liberated from the APP by the concerted action of two
proteases, termed - and -secretase (Kao et al., 2004; Small and
Gandy, 2006; Haass and Selkoe, 2007). Endocytosis of APP is
required to initiate cleavage by the-secretase BACE (-secretase
activity of the -site APP-cleaving enzyme) (Small and Gandy,
2006; Vetrivel and Thinakaran, 2006). The “YENPTY” motif lo-
cated near the C terminus of APPmediates its internalization and
also serves as docking site for several APP adaptor proteins with
phosphotyrosine-binding domains, such as X11, Fe65, Shc, and
JIP (King and Scott Turner, 2004). Interestingly, some of these
adaptor proteins link APP to apolipoprotein E (apoE) receptors
of the low-density lipoprotein receptor (LDLR) family (Zerbi-
natti and Bu, 2005). By this mechanism, the uptake of
cholesterol-rich apoE particles via LDLR also modulates the en-
docytosis and the amyloidogenic processing of APP (Kounnas et
al., 1995; Pietrzik et al., 2002; Ye et al., 2005), and several studies
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have demonstrated that membrane cholesterol levels influence
the generation of A (Simons et al., 1998; Frears et al., 1999;
Fassbender et al., 2001; Abad-Rodriguez et al., 2004).
Here, we further tighten the relationship of cholesterol and
APP by demonstrating a role of flotillin and cholesterol in endo-
cytosis and -cleavage of APP in neurons.
Materials andMethods
Transgenic animals, cell culture, transfection, and viral infection.Heterozy-
gous B6C3 swAPP/PS1dE9 mice harboring the Swedish mutation and
human PS1 encoding the exon 9 deletion mutation were obtained from
The Jackson Laboratory (Bar Harbor, ME).
Mouse neuroblastomaN2a cells were cultured as described previously
(Rajendran et al., 2006). At 24 h after seeding of N2a cells on glass cov-
erslips or into 3.5 cm dishes, cells were transfected with Fugene (Roche,
Basel, Switzerland) according to the protocol of the manufacturer.
A stable N2a cell line expressing short hairpin RNA (shRNA) directed
against flotillin-2 was created with the forward target sequence
5GATCTCCGATCCTCAGCTTCACCATCAATTCAAGAGATTGAT-
GGTGAAGCTGAGGATCTTTTTGGAAA3 and the reverse target se-
quence 5AGCTTTTCCAAAAAGATCCTCAGCTTCACCATCAA-
TCTCTTGAATTGATGGTGAAGCTGAGGATCGGA3. The annealed
oligos were cloned into pSUPER, and retroviruses were produced in a
Phoenix gag-pol retroviral packaging cell line and used to infect N2a
cells. A control cell line was produced expressing the empty vector. N2a
cells were selected for growth in hygromycin.
RNA oligonucleotides were delivered into N2a cells using Oligo-
fectamine (Invitrogen, Karlsruhe, Germany) according to the instruc-
tions of the manufacturer. In experiments in which a combination of
small interfering RNA (siRNA) and plasmid delivery was necessary, plas-
mids were transfected with Fugene 36 h after siRNA delivery. Endocyto-
sis was assessed 16 h later. The following siRNAswere used: GUUCAUG-
GCAGACACCAAGTT against flotillin-1 and GAUCCUCAGC-
UUCACCAUCAATT against flotillin-2 (Ambion, Austin, USA), RNA
duplex oligonucleotides with overhanging dTs directed to conserved re-
gions in murine adaptor protein-2 (AP-2) 2b GUGGAUGCCU-
UUCGCGUCAdTdT and UCAAGCGCAUGGCAGGCAUdTdT (Qia-
gen, Hilden, Germany) were used in combination. Control siRNA was
obtained from Ambion (control siRNA #1) or from Qiagen (MBP
siRNA; N2a cells do not express MBP).
Primary hippocampal neurons derived from mouse embryos were
cultured on poly-lysine-coated glass coverslips or plastic dishes as de-
scribed previously (Simons et al., 1998). Neurons were kept under
serum-free conditions inMEMwith B27 supplement for 5 d before a 1 h
infection with recombinant Semliki Forest virus (SFV) encoding human
APP695-myc with the double-mutation K670N and M671L (Swedish
mutation) or with recombinant adenovirus encoding cyan fluorescent
protein (CFP)–APP bearing the Swedish double mutation K670N plus
M671L. After medium exchange, the cells were incubated for 8 h in the
case of SFV and 16 h in the case of adenovirus infection before additional
experimental processing.
Flotillin-2 siRNA was delivered into hippocampal neurons by nucleo-
fection with Amaxa (Cologne, Germany) basic neuron kit according to
the protocol of themanufacturer shortly before plating. After 4 d in vitro,
neurons were infected with adenovirus, and endocytosis experiments
were performed 12–16 h later.
Cholesterol depletion. For cholesterol depletion, cells were washed
three times with HBSS, followed by a 2 h incubation with 1 mM methyl-
-cyclodextrin (mCD) in HBSS at 37°C. For the subsequent experi-
ments, we used medium that was supplemented with lipoprotein-free
serum.
Immunoprecipitation and quantification. For coimmunoprecipitation
of APP and flotillin-2, N2a cells were grown in 3.5 cmdishes and cotrans-
fected, and cell lysates were prepared in lysis buffer consisting of 1%
3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate, 150
mM NaCl, 5 mM EDTA, and 50 mM Tris, pH8, supplemented with a
protease inhibitormixture (Roche). Immunoprecipitates were recovered
on protein A/G Plus agarose beads (Santa Cruz Biotechnology, Santa
Cruz, CA). Samples were subjected to Western blot analysis; bands were
quantified using the NIH ImageJ software. Metabolic labeling experi-
ments, immunoprecipitation of medium and cell lysates, Tris-tricine or
polyacrylamide electrophoresis, and quantification of the bands were
done as described previously (Ehehalt et al., 2003).
Plasmids, antibodies, and reagents. The following plasmids were used:
mutant and wild-type (wt) cDNAs of green fluorescent protein (GFP)–
dynaminII (Sandra Schmid, Scripps Research Institute, La Jolla, CA);
p-cytomegalovirus (pCMV)–myc–AP180 C terminus and pCMV–myc–
epsin (R63LH73L) (Harvey McMahon, Medical Research Council,
Laboratory of Molecular Biology, Cambridge, UK); pCMV–AP180–
GFP; pCMV–epsin1–GFP (Peter McPherson, Montreal Neurological
Institute,McGill University,Montreal, Quebec, Canada); pCMV–wtAP-
P–myc (Tobias Hartmann, Neurodegeneration and Neurobiology, Uni-
versity of Saarland, Saarland, Germany); pShuttleCMV–swAPP, pShut-
tleCMV–CFP–swAPP, pShuttleCMV–swAPP–yellow fluorescent
protein (YFP), pShuttleCMV–swAPP, p–enhanced YFP (EYFP)–N1
(Clontech, Mountain View, CA), flotillin-1–GFP (Ben Nichols, Medical
Research Council, Laboratory of Molecular Biology, Cambridge, UK),
flotillin-2–GFP, flotillin-2–red fluorescent protein (RFP) (the GFP was
removed using Age1 and BsrG1, and the mRFP generated by PCR am-
plification was cloned back into the original flotillin-2–GFP vector);
pR4– proteolipid protein (PLP)–myc; and vesicular stomatitis virus pro-
tein (VSVG-A)–GFP–LTLM9 (Patrick Keller, Max-Planck-Institute for
Molecular Cell Biology and Genetics, Dresden, Germany).
Antibodies were obtained from the following sources: mouse mono-
clonal antibodies against AP-2, flotillin-1, and flotillin-2, monoclonal rat
anti-LAMP-1 (lysosome-associated membrane protein-1) (BD Bio-
sciences, Heidelberg, Germany), mouse monoclonal antibody against
III-tubulin (Promega, Mannheim, Germany), rabbit anti-calnexin
(Stressgen Bioreagents, Victoria, British Columbia, Canada), mouse
monoclonal anti-myc (Cell Signaling Technology, Denver, CO), rabbit
anti-GFP (Abcam, Cambridge, UK), monoclonal antibody 6E10, di-
rected against the 3–8 region of the A peptide (Covance Research Prod-
ucts, Princeton, NJ), polyclonal antibody IP60 recognizes the C terminus
of APP, rabbit antibody 70JE is raised against amino acids 1–11 of the A
peptide, polyclonal antibody ANJJ is directed against the C terminus of
soluble swAPP, and B63-3 monoclonal antibody recognizes the C ter-
minus of APP (kindly provided by Bart de Strooper, Department of
Human Genetics, Katholieke Universiteit Leuven, Leuven, Belgium).
O10 (monoclonalmouse IgM) recognizes PLP, and anti-VSVG antibody
was provided by Patrick Keller.
The fluorophore-conjugated secondary antibodies Alexa Fluor 488,
cyanine 3 (Cy3)–IgG, andCy5were purchased fromDianova (Hamburg,
Germany), Alexa Fluor 488-f(ab)-fragment was from Invitrogen, and
Cy3-f(ab)-fragment was from Jackson ImmunoResearch (Newmarket,
UK).
The following reagents were used: rhodamine-conjugated transferrin,
rhodamine–dextran (Mr of 10 kDa) (Invitrogen), DiI–LDL (generous
gift from Jobst Landgrebe, Center for Biochemistry and Molecular Cell
Biology, University of Go¨ttingen, Go¨ttingen, Germany), mCD, and
cycloheximide (Sigma, Schnellendorf, Germany).
Microscopy and analysis. Fluorescence images were acquired on a Leica
(Mannheim, Germany) DMRXAmicroscope or a Zeiss (Jena, Germany)
LSM 510 confocal microscope with a 63 oil plan-apochromat objective
(numerical aperture 1.4; Zeiss). Image processing and analysis was per-
formed using Meta Imaging Series 6.1 software (Universal Imaging,
Downingtown, PA). Quantification of fluorescence intensities was per-
formed as reported previously (Trajkovic et al., 2006).
The stimulated emission depletion (STED) microscope has been de-
scribed previously (Dyba et al., 2003). Fluorescence excitation was per-
formed with a pulsed laser diode emitting 100 ps pulses at 470 nm (Pi-
coquant, Berlin, Germany), whereas STED used 280 ps pulses with a
repetition rate of 250 kHz at 603 nm, generated by a optic parametric
amplifier being pumped through a regenerative amplified titanium:sap-
phire laser (Coherent, Santa Clara, CA). The conversion of the STED
beam into a doughnutmodewas accomplished bymeans of a spatial light
modulator (Hamamatsu, Hamamatsu City, Japan) delivering a (0–2)
helical phase ramp. The excitation diode was electronically triggered by
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the RegA pulses; the appropriate delay between the pulses was adjusted
with an electronic delay generator. The excitation and the STED beams
were coupled into an oil immersion lens (HCX PL APO, 100; Leica)
with a 1.4 numerical aperture, bymeans of dichroicmirrors. The average
power of the excitation beam and the STED beam in the sample was 50
nW and 240 W, respectively. The fluorescence was collected by the
same lens and directed into a counting avalanche photodiode
(PerkinElmer, Vaudreuil-Dorian, Canada). The photodiode featured an
opening diameter of70%of the backprojected Airy disk at the detector
plane. The image was obtained by scanning the sample with a piezo stage
featuring a positioning accuracy10 nm. For analysis of cluster sizes in
STED images, the diameters of individual clusters were measured using
MetaMorph software.
For fluorescence lifetime measurements, flotillin-2 or control siRNA-
treated cells were transfected with swAPP cDNA. Anti-APP antibody
6E10 was incubated at a final concentration of 0.1 mg/ml with an eight-
fold molar excess of anti-mouse f(ab) in imaging buffer (PBS, 10 mM
HEPES, pH 7.2, and 0.1% BSA) for 90 min at 4°C; f(ab) had been either
coupled to Alexa 488 [digested from Alexa 488 f(ab)2 (Invitrogen) using
immobilized papain (Pierce, Rockford, IL)] or to Cy3 (Jackson Immu-
noResearch) or was unmodified (Jackson ImmunoResearch). After in-
cubation, 6E10- f(ab)-Alexa 488 was mixed at a ratio of 1:3 with either
6E10–f(ab) or 6E10–f(ab)–Cy3; this corresponds to a1:3 molar ratio
of Alexa 488 toCy3. At 24 h after swAPP transfection, cells were cooled to
4°C and incubated for 20minwith the freshly prepared antibodymixture
at a final 6E10 concentration of 0.02 mg/ml, washed thoroughly,
mounted in imaging buffer, and imaged at 20°C on a frequency-domain
fluorescence lifetime imagingmicroscope (Esposito et al., 2005) using an
argon laser (Innova 300; Coherent) at 488 nm and 250 mW. The filter
cube contained a long-pass 495 dichroic and a band-pass 515/30 emis-
sion filter. The pixel lifetimes in all measured cells were globally fitted to
correct for background fluorescence and absolute intensity effects (M.
Gralle and F. S. Wouters, unpublished routines), and the distribution of
true lifetimes was calculated. Fo¨rster resonance energy transfer (FRET)
efficiencies in each FRET condition were calculated relative to the mean
true lifetime of the corresponding donor only sample.
Endocytosis assays and quantification. Cells expressing the appropriate
CFP–APP or APP–YFP constructs (delivered by either transfection or
viral infection) were washed with cold HBSS, cooled down, and labeled
for 20–30min at 4°Cwithwhole serum rabbit anti-GFP antibody (1:100)
in HBSS. Unbound antibody was removed by three washes with HBSS
before placing the cells in prewarmed (37°C) normal growth medium
(supplemented with lipoprotein-free serum in the case of previous cho-
lesterol depletion). After internalization of bound label for various time
intervals, medium was washed off with HBSS, and surface retained anti-
GFP antibody was labeled at 4°C for 30–40 min with Cy5 anti-rabbit
antibody (7.5 ng/l) in HBSS, followed by extensive washing with cold
HBSS and fixation. Cells were then permeabilized, and anti-GFP anti-
body was immunostained with Cy3 anti-rabbit antibody. AlexaFluor
555–transferrin endocytosis was performed as a continuous uptake.
For quantification, confocal images were taken with identical acquisi-
tion parameters. To quantify APP endocytosis, fluorescence intensities of
cell-surface retained APP (Cy5 signal originating from the cell surface)
and internalized APP (Cy3 signal from the cell interior) were measured
withMetaMorph software. The region, corresponding to the cell surface,
was identified by the Cy5 signal, and the cell interior was defined as the
region within. The ratio of cell interior-derived Cy3/surface-derived Cy5
fluorescence intensity was calculated as a measure for endocytosis.
For clustering experiments, swAPP-expressing cells were labeled with
monoclonal antibody 6E10 for 30 min at 4°C, washed three times, and
incubated with bivalent IgG Cy3–IgG anti-mouse antibody, with mono-
valent Cy3–f(ab) anti-mouse fragment, or without secondary antibody
for an additional 30 min at 4°C. After extensive washing, cells were
shifted for various time intervals to 37°C to allow endocytosis to occur.
Cells were then fixed and stained with wheat germ agglutinin (WGA),
and confocal imageswere taken. The cell surface outlinewas identified by
theWGA staining. The internalization of APPwas quantified withMeta-
Morph software as the ratio of fluorescence intensity originating from
the cell interior versus intensity of the total cell. Clustering experiments
for VSVG or PLP transfected cells were performed according to the same
protocol with anti-VSVG or anti-PLP antibodies.
Biotinylation and internalization of cell surface APP. N2a cells were
grown on 5 cm dishes and transfected withmyc–APP 12 h before surface
biotinylation. Cholesterol depletion or siRNA-mediated knockdown of
flotillin-2 was done as described above. Cells were cooled to 4°C, washed
with PBS, and labeled with 0.125 mg/ml reducible sulfo-NHS-SS-Biotin
(Pierce) in PBS for 20min at 4°C. After washing with PBS and quenching
of unreacted biotin with 50 mM glycine, cells were either subjected to 15
min endocytosis by a 37°C incubation in prewarmed medium (supple-
mented with delipidated medium in cholesterol depletion experiments)
or left at 4°C to determine the amount of biotinylated surface APP. In the
case of endocytosis, remaining cell-surface biotin was cleaved with 100
mM DTT, and free DTT was quenched with 5 mg/ml Iodacetamide in
PBS. Cells were lysed in PBS, 1% NP-40, 0.1% SDS, and a protease
inhibitor mixture. Five percent of total lysates were used to determine
transfection levels by Western blotting. Biotinylated surface or biotinyl-
ated endocytosed proteins were precipitated with neutravidin beads, and
biotinylated APP was detected by Western blotting and normalized
against the amount of APP in the respective total cell lysates. Blots were
scanned, and the ratios of endocytosed versus surface APP were
determined.
Results
Flotillin influences APP processing
To study the role of flotillin in APP processing (Fig. 1A), we used
the neuronal cell line mouse neuroblastoma N2a, because these
cells lack caveolae but abundantly express flotillin. By siRNA-
mediated knockdown, the expression of flotillin-1 and -2 was
reduced by70% (Fig. 1B). Flotillin knockdown cells were sub-
sequently infected with adenovirus to express the Swedish mu-
tant of APP (swAPP), which is dominantly-cleaved, resulting in
several fold higher production of A compared with wild-type
APP (Citron et al., 1992). After 40 min of metabolic labeling and
a 2 h chase, cell lysates and medium were subjected to immuno-
precipitation with antibodies against the various APP fragments
(Fig. 1A) (Rajendran et al., 2006). Immunoprecipitation from
conditionedmedium revealed that the generation of bothA and
the soluble -cleaved ectodomain (sAPP) were reduced by
flotillin-2 knockdown (37 and 59% reduction, respectively) (Fig.
1C,D). Analysis of the remaining COOH-terminal fragments of
APP (CTFs) in the cell lysate shows that both- and-CTFswere
diminished (40 and 29% reduction) (Fig. 1C,D). In contrast,
knockdown of flotillin-1 levels did not interfere with the process-
ing of APP.
Whereas RNAi-mediated knockdown of flotillin-1 only af-
fected the expression of flotillin-1, knockdown of flotillin-2 de-
creased the protein levels of both flotillin-1 and flotillin-2 (sup-
plemental Fig. 1A–C, available at www.jneurosci.org as
supplemental material). This is consistent with a recent report
that showed proteasomal degradation of flotillin-1 after silencing
of flotillin-2 (Solis et al., 2007).We therefore used flotillin-2 RNA
interference (RNAi) for all subsequent experiments to obtain a
knockdown of both flotillin isoforms.
Flotillin modulates the endocytosis of APP
Previous studies have shown that APP endocytosis is required for
-cleavage to occur. Although a significant fraction of the Swed-
ish mutant of APP is already processed by -secretase during
transport through the biosynthetic pathway (Haass et al., 1995),
inhibition of endocytosis in N2a cells markedly reduces
-cleavage of swAPP inN2a cells (Perez et al., 1996; Ehehalt et al.,
2003; Rajendran et al., 2006). Given a recently proposed flotillin-
dependent endocytosis pathway (Glebov et al., 2006) and the
reduction of amyloidogenic APP processing after flotillin knock-
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down detected here, we investigated whether flotillin regulated
the endocytosis of APP. We created stable N2a cell lines express-
ing shRNAdirected against flotillin-2 and control cells expressing
the backbone vector without the flotillin-2 shRNA. The success-
ful depletion of flotillin mRNA (90%) and protein levels
(70%) was confirmed by real-time reverse transcription-PCR
and Western blotting (data not shown). To analyze whether the
reduction of flotillin-2 affected the endocytosis of APP, we trans-
fected a CFP–swAPP fusion protein (Ehehalt et al., 2003) into the
stably expressing flotillin-2 shRNA and control cells and per-
formed a quantitative immunofluorescence-based APP endocy-
tosis assay. In this assay, cell surface APP was labeled by incubat-
ing cells on ice with an antibody against the N-terminal CFP.
After washing, cells were incubated at 37°C for different time
spans (5, 20, and 45 min) to allow internalization of antibody-
bound APP. Cells were subsequently incubated on ice with a
Cy5-conjugated secondary antibody to visualize cell-surface re-
tained APP. After fixing and permeabilization, internalized APP
was visualized using a secondary Cy3-conjugated antibody di-
rected against the rabbit anti-CFP primary antibody. During the
time course of internalization, APP gradually disappeared from
the cell surface and accumulated within the cell (Fig. 2A). No
antibody uptakewas observedwhenuntransfected cells were sub-
jected to this endocytosis assay. In
flotillin-2 knockdown cells, a significant
reduction of swAPP internalization was
observed in this assay compared with con-
trol cells (44% reduction) (Fig. 2B),
whereas overexpression of flotillin-2 stim-
ulated the endocytosis of APP (Fig. 2D).
Importantly and consistentwith a previous
report, flotillin-2 knockdown did not in-
terfere with the uptake of rhodamine–
transferrin, ruling out unspecific off-target
effects on clathrin-dependent endocytosis
(Fig. 2B) (Glebov et al., 2006).We also ob-
served a reduction of the endocytosis of
wild-type APP after depleting flotillin-2
with siRNA oligonucleotides (Fig. 2B). In
contrast to the effect observed for
flotillin-2 knockdown on APP internaliza-
tion, APP endocytosis was not impaired by
knockdown of flotillin-1 (supplemental
Fig. 2A, available at www.jneurosci.org as
supplemental material), which is consis-
tent with our finding, that only flotillin-2
affects the processing of APP.
Similar results were obtained in pri-
mary cultures of hippocampal neurons,
which, likeN2a cells, do not express detect-
able levels of caveolin but produce large
amounts of flotillin (Cameron et al., 1997).
Flotillin-2-specific siRNA was delivered
into hippocampal neurons by nucleofec-
tion, which resulted in an70% reduction
of both flotillin-1 and flotillin-2 protein
levels (supplemental Fig. 1B,C, available at
www.jneurosci.org as supplemental mate-
rial). Neurons were infected with recombi-
nant adenovirus to express CFP–swAPP
4–5 d after nucleofection. Antibody-
uptake experiments revealed that
flotillin-2 knockdown reduces the inter-
nalization of APP by 68% compared with control siRNA
nucleofected neurons (n 154 cells, p 0.0005, t test) (Fig. 2C).
Together, our results show that flotillin-2modulates-secretase-
mediated processing of APP by regulating its endocytosis.
Our results are surprising because flotillin-1 has been impli-
cated previously in the regulation of a clathrin- and caveolin-
independent pathway (Glebov et al., 2006), although it is well
established that APP is internalized in a clathrin-dependentman-
ner (Koo and Squazzo, 1994; Koo et al., 1996; Perez et al., 1999).
Because the endocytosis of APP has mainly been studied in cells
of non-neuronal origin, we speculated that APP may use an al-
ternative pathway in neuronal cells. To test whether APP endo-
cytosis is clathrin dependent in N2a cells, we performed internal-
ization assays in cells, which were either depleted of AP-2 by
siRNA or expressed dominant-negative mutants of AP180 or dy-
namin to interfere with the clathrin-dependent endocytosis ma-
chinery (Fig. 3). RNA interference with AP-2 resulted in an
60% downregulation of the protein (supplemental Fig. 1D,
available at www.jneurosci.org as supplemental material), which
reduced the endocytosis of both APP and rhodamine–transferrin
(Fig. 3). A similar inhibition of APP endocytosis and rhodamine–
transferrin uptake was achieved by expression of dominant-
negative mutants of AP180 and dynamin, indicating that APP
Figure 1. Flotillin-2 regulates amyloidogenic processing of APP. A, Schematic representation of human APP, membrane
topology, its cleavage products, and epitopes of the antibodies used.B, Western blot analysis of N2a cell lysates transfectedwith
flotillin-1 (left) or flotillin-2 (right) specific siRNA. Transferrin-receptor (Tf-Rec) levels (top) are used as a loading control; the
bottom shows the same lysates, probed with either a flotillin-1 (left) or flotillin-2 (right) specific antibody. C, Metabolic labeling
of mock, flotillin-1, or flotillin-2 siRNA-transfected N2a cells. After adenovirus-mediated delivery of swAPP, cells were metabol-
ically labeled and chased for 2 h. Immunoprecipitates from cell lysates and medium were performed with the antibodies IP60,
70JE, and ANJJ to detect swAPP, CTFs, A, and soluble swAPP (s-swAPP), respectively. D, Full-length APP and cleavage
products were quantified; values ofmock transfected controls were normalized to 1, and all values are given as themean SEM
from four experiments.
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requires clathrin function for its endocytosis in N2a cells (AP-2
RNAi: 99% reduction of APP endocytosis, 71% reduction of
transferrin endocytosis; AP180 C terminus: 69% reduction of
APP endocytosis, 79% reduction of transferrin uptake;
dynaminK44a: 75% reduction of APP endocytosis, 62% reduc-
tion of transferrin uptake) (Fig. 3). However, when we expressed
a dominant-negative form of the clathrin accessory protein ep-
sin1, which is unable to bind to phosphatidylinositol-4,5-
bisphosphate (Ford et al., 2002), we observed an interesting dif-
ference between APP and transferrin endocytosis. Although
mutant epsin1 efficiently inhibited rhodamine–transferrin up-
take as reported previously (Ford et al., 2002; Deinhardt et al.,
2006), it did not show any effect on the endocytosis of APP
(dominant-negative epsin1: 9% increase in APP endocytosis,
55% reduction of transferrin uptake) (Fig. 3). These results sug-
gest that APP may be internalized by a specialized clathrin-
dependent mechanism using a specific subset of accessory pro-
teins. Our findings closely resemble an endocytosis pathway that
has been described for the internalization of tetanus toxin into
motor neurons (Deinhardt et al., 2006). The neurospecific teta-
nus toxin binds to polysialogangliosides within cholesterol-rich
lipid microdomains before internalization by a clathrin-
dependent pathway that requires AP-2 but is independent of ep-
sin1 (Herreros et al., 2001; Deinhardt et al., 2006). APP can bind
to gangliosides via its A region (Yanagisawa et al., 1995). This
and the fact that cholesterol depletion interferes with -secretase
processing of APP (Simons et al., 1998) led us to speculate
whether cholesterol might play a role also in the endocytosis of
APP. The conditions for cholesterol depletionwere established so
that endocytosis of transferrin was not affected. When N2a cells
were pretreated for 2 hwith 1mMmCD to extract plasmamem-
brane cholesterol, we did not observe a reduction of rhodamine–
transferrin or DiI–LDL uptake (supplemental Fig. 2A,B, avail-
able at www.jneurosci.org as supplemental material). However,
the internalization of APP was significantly impaired (57% re-
duction, n 1030 cells, p 0.0005, t test), which was accompa-
nied by reduced-cleavage of APP (52% reduction, n 228 cells,
p 0.0005, t test). Similar results were obtained in primary cul-
tures of hippocampal neurons (90% reduction of APP endocyto-
sis, 35% reduction of intracellular sAPP).
When we compared the APP endocytosis rates of cholesterol-
depleted or untreated cells using a biotinylation assay, we found a
62% reduction in APP endocytosis, confirming the results of the
immunofluorescence-based assay (supplemental Fig. 3A, avail-
Figure 2. Flotillin-2 knockdown inhibits APP endocytosis in N2a cells and primary hippocampal neurons. A, CFP–swAPP-transfected N2a cells were labeled at 4°C with anti-GFP antibody,
washed, and incubated at 37°C for 5, 20, and 45 min to allow internalization of antibodies bound to CFP–swAPP. To visualize cell-surface retained APP, cells were labeled with Cy5-conjugated
secondary antibody at 4°C (pseudocolored in blue). After fixing, cells were permeabilized and stained with a Cy3-conjugated secondary antibody to resolve internalized APP (red). The cell surface
was identified on confocal sections by the Cy5 label, and APP endocytosis was measured by calculating the intensity ratio of (cell interior Cy3)/(surface Cy5) labeled CFP–swAPP. The graph shows
the increase in internalized APP over the time course of 45 min, the corresponding confocal images display the increasing amount of internalized APP (Cy3), whereas Cy5-labeled surface APP
decreases over time (n 95 cells, values representmeans SEM; *p 0.05; ***p 0.0005, t test). Scale bar, 10m.B, Antibody-uptake experiment of transiently transfected CFP–swAPP in
flotillin-2 knockdown (gray bars) and control cells (white bars). Endocytosis of APP (40min, 37°C)was determined as ratio of Cy3- to Cy5-labeled CFP–swAPP. swAPP endocytosis is reduced by 44%
after flotillin-2 downregulation, whereas uptake of rhodamine–transferrin is not significantly altered. Similar results were obtained for wtAPP, in which the uptake was reduced by 60% after
flotillin-2 knockdown. Values are shown as means SEM [n 990 cells (swAPP endocytosis), n 1251 cells (transferrin uptake), n 154 cells (wtAPP endocytosis); **p 0.005; ***p
0.0005, t test]. The confocal imagesdepict the reducedamountof internalized swAPPafter flotillin-2 knockdown (left) comparedwith control cells (right). Scale bar, 10m.C, Primaryhippocampal
neurons were transfected with flotillin-2-specific siRNA or a control siRNA before plating. After 4 d, cells were infected with adenovirus to express CFP–swAPP, and APP uptake was measured.
Representative confocal images are shown. Scale bar, 10 m. D, N2a cells were transiently transfected with pEYFP–N1 vector or increasing amounts of flotillin-2–GFP DNA (80 and 180 ng
DNA/cm 2), and endocytosis of cotransfected CFP–swAPPwasmeasured as described in A–C. Values of internalized/surface retained APPwere normalized to YFP-expressing controls and given as
means SEM, n 208 cells, ***p 0.0005, t test.
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able at www.jneurosci.org as supplemental material). RNAi-
mediated flotillin-2 knockdown led to a 87% reduction of APP in
the biotin endocytosis assay compared with control siRNA-
treated cells (supplemental Fig. 3B, available at www.jneuro-
sci.org as supplemental material).
Together, these results suggest that APP internalization occurs
via a specialized clathrin-dependent pathway that is modulated
by cholesterol and flotillin-2.
Flotillin modulates clustering of APP
Consistent with previous studies (Stuermer et al., 2001;
Neumann-Giesen et al., 2007), we found flotillin in the endoso-
mal system and at the plasma membrane of N2a cells and hip-
pocampal neurons (data not shown), in which it colocalized par-
tially with clusters of surface labeled APP (Fig. 4A). This
observation together with the putative function of flotillin as a
domain-organizing scaffold that entraps specific lipids and pro-
teins in membrane microdomains prompted us to investigate
whether flotillin could organize APP in larger clusters and
whether such clustering could play a role in APP endocytosis.
To visualize the clustering behavior of APP, we used STED
microscopy (Donnert et al., 2006) that provides a nanoscale res-
olution (40 nm laterally, corresponding to the applied STED
power in this study) (Fitzner et al., 2006; Willig et al., 2006).
Using STEDmicroscopy, we compared the size of APP clusters in
the plasmamembrane of control cells and cells that were depleted
of flotillin-2 by RNAi (Fig. 4B). Remarkably, we found that the
flotillin-2 knockdown resulted in a significant reduction of mean
APP cluster sizes (77% reduction, 900 clusters counted, p 
0.0001, t test). The size distribution of APP clusters was shifted
toward lower cluster sizes in flotillin-2-depleted cells (Fig. 4C),
suggesting that flotillin-2 may be involved in the clustering of
APP at the plasma membrane. In contrast, knockdown of
flotillin-1 did not affect cluster size and size distribution of sur-
face APP (data not shown).
The effect of flotillin-2 knockdown onAPP clusteringwas also
investigated by the technique of FRET, which is particularly suit-
able for observing phenomena occurring at a scale of 10 nm
(Bunt andWouters, 2004). Donor and acceptor dyes were exclu-
sively coupled to surface swAPP molecules by incubation of
swAPP-transfected N2a cells with antibody-coupled dyes at 4°C.
Despite the low signal attributable to the low concentration of
surface APP, it was possible tomeasure resonance energy transfer
between donor and acceptor dye molecules.
In flotillin-2-depleted cells, the absolute intensity of the
bound dyes was higher, apparently attributable to lower endocy-
tosis rates; mean FRET efficiency was 3.2%. In control cells only,
an additional subpopulation of swAPP underwent energy trans-
fer with a higher FRET efficiency centered around 12%. This
redistribution to a new subpopulation, with a loss at lower and
gain at higher FRET efficiencies, induced by flotillin-2 is visible in
the difference of the distributions (Fig. 4D) and introduces a
significant difference ( p  0.01) between the mean FRET effi-
ciencies of control and flotillin-2-depleted cells. APP is therefore
more likely to homotypically interact in the presence of
flotillin-2. This result is compatible with the reduction of APP
cluster size during flotillin-2 knockdown as seen by STED mi-
croscopy. The low mean values of the average FRET efficiencies
probably reflect the large distance between the dye molecules
coupled to secondary f(ab) fragments on separate primary anti-
body molecules bound to separate swAPP molecules.
A previous study has provided evidence that flotillin interacts
with APP via residues 189–282 of its proposed oligomerization
domain (Chen et al., 2006), suggesting that direct protein–pro-
tein interaction between APP and flotillin oligomersmight be the
driving force in the formation of APP clusters. Indeed, by coim-
munoprecipitation, we found an interaction of APP and
flotillin-2 not only in N2a cell culture but also in brain lysates
from heterozygous swAPP/PS1dE9 transgenicmice (supplemen-
tal Fig. 4, available at www.jneurosci.org as supplemental mate-
rial). Because flotillin partitions into lipid rafts, we speculated
that the interaction between APP and flotillin would be sensitive
to cholesterol depletion. Indeed, the amount of flotillin-2 that
was coimmunoprecipitated with APP was significantly reduced
by cholesterol depletion (51% reduction) (supplemental Fig. 4,
available at www.jneurosci.org as supplementalmaterial), raising
the possibility that, in addition to the direct protein interaction,
protein–lipid interactions may contribute to the complex
formation.
We hypothesized that the flotillin-driven clustering of APP
might be amechanism to influence its endocytosis. If this were to
be the case, then artificial clustering of APP by antibody cross-
linking should overcome the inhibitory effect of flotillin-2 knock-
downon the endocytosis of APP. To test this possibility, we trans-
fected swAPP–YFP into N2a cells and labeled APP at the cell
surface with primary antibody at 4°C, followed by the subsequent
incubation with monovalent f(ab) fragment or with bivalent IgG
secondary antibody to induce clustering of APP. Cells were then
shifted to 37°C to allow endocytosis to occur. Cross-linking with
bivalent secondary antibody dramatically stimulated the endocy-
tosis of APP (64% increase, n 170 cells, p 0.0005, t test) but
not of two other transmembrane proteins [VSVG and PLP (sup-
plemental Fig. 5, available at www.jneurosci.org as supplemental
material)]. In line with the stimulation of endocytosis, we ob-
served an increase in intracellular -cleaved APP ectodomain
during antibody induced clustering (52% increase, n 406 cells,
p  0.005, t test) as reported previously (Ehehalt et al., 2003).
Having shown that antibody-induced clustering promotes endo-
cytosis of APP, we tested the possible role of flotillin in this pro-
cess. APP was labeled at the cell surface with primary antibody
and cross-linked with bivalent IgG secondary antibody or not in
both control and flotillin-2-depleted cells. The rate of endocyto-
Figure3. APP endocytosis occurs in a distinct clathrin pathway independent of epsin1 and is
regulatedby cholesterol. N2a cellswere cotransfectedwith CFP–swAPPand siRNAagainst AP-2
or control siRNA or plasmids encoding for the dominant-negative (dn) mutant myc–AP180–C
terminus, the wild-type control AP180–GFP, dominant-negative dynaminK44A–GFP, wild-
type dynamin–GFP, dominant-negative myc– epsin1, or wild-type epsin1–GFP. Expression
time of all constructs was below 12 h, and cells did not display any signs of toxicity. APP
endocytosis was determined by an antibody uptake assay with anti-GFP antibody; clathrin-
dependent endocytosis was assessed by transferrin–rhodamine uptake. Internalization was
quantified by analysis of confocal images (Cy3/Cy5 ratio for APP, rhodamine intensity for trans-
ferrin). Results are shownasmeans SEM (n100 cells for each condition, *p0.05; **p
0.005; ***p 0.0005, t test). Note that dominant-negative epsin1-expressing cells show a
significant reduction of transferrin (Tf) uptake but no impairment of APP endocytosis.
Schneider et al. • Flotillin in the Endocytosis and Processing of APP J. Neurosci., March 12, 2008 • 28(11):2874–2882 • 2879
sis was determined over a time course of 15 and 30 min. Consis-
tent with our results above, we found that depletion of flotillin-2
reduced the internalization of APP in the absence of IgG second-
ary antibody (Fig. 5A). However, when endocytosis was pro-
moted by incubating cells with bivalent secondary antibody, we
observed that the inhibition by flotillin-2 knockdown was com-
pletely overcome (Fig. 5A). Antibody-induced clustering of APP
might, thus, mimic the function of flotillin in modulating APP
endocytosis.
Similar results were obtained in cells depleted of cholesterol,
in which the inhibitory effect of cholesterol depletion could be
reversed by secondary IgG antibody-mediated clustering of APP
(Fig. 5B).
Discussion
Endocytosis is required for the amyloidogenic processing of APP
and thus to initiate the release of the neurotoxic A peptide.
Here, we demonstrate that flotillin-2 promotes the clustering of
APP, and this may stimulate the sequential endocytosis of APP
into a specialized clathrin-dependent endocytosis pathway.
Clathrin-dependent and cholesterol-dependent endocytosis
pathways have been primarily regarded as mutually exclusive.
However, there are a number of examples suggesting an overlap
between cholesterol- and clathrin-dependent pathways. An in-
teresting example is the anthrax toxin that clusters its receptor
into lipid rafts, thereby triggering clathrin-dependent endocyto-
4
smaller cluster sizes in the flotillin-2 knockdown cells, the confocal image cannot recall the
individual, separate clusters as identified by the STED image (arrows). C, The histogram depicts
the percentage of APP clusters within the respective indicated cluster size limit (gray bars,
flotillin-2 knockdown cells; red bars, control cells). Note that, in flotillin-2-depleted cells, most
clusters are found in the range of 0–700, whereas cluster sizes are shifted to higher values in
control cells. Cluster sizes are given as numbers of pixels and represent mean values (n 290
and 616 clusters for control and knockdown cells, respectively). D, Effect of flotillin-2 knock-
down on APP homotypic interactionmeasured by FRET in live cells. N2a cells were treatedwith
either flotillin-2 or control siRNA and transfected with swAPP. Surface APP was stained with
6E10 anddye-coupled secondary antibody f(ab) fragments, and energy transfer fromdonor dye
Alexa 488 to acceptor dye Cy3 was measured by the reduction of the lifetime of Alexa 488. The
difference in FRET efficiency distribution of control cells, compared with flotillin-2-depleted
cells, is shown. Red bars, FRET efficiencies more populated in control cells. Gray bars, FRET
efficiencies more populated in flotillin-2-depleted cells.
Figure 4. Flotillin-2 increases the size of cell-surface APP clusters on a nanoscale resolution.
A, Partial colocalization (arrows) of surface APP and flotillin-2. N2a cells were transfected with
CFP–swAPP, and surface APP was stained at 4°C with an antibody directed against CFP. After
fixation, anti-CFP labeling and endogenous flotillin-2 were visualized by indirect immunofluo-
rescence (surface APP green, endogenous flotillin red). Scale bar, 10 m. B, N2a cells either
stably expressing a control shRNA (Flot-2, left) or shRNA directed against flotillin-2 (Flot-2
, right). Cells were transfected with CFP–swAPP, and surface APPwas labeled with anti-GFP
antibody for 30 min on ice before fixation. Cells were visualized by confocal microscopy (top)
and by T-Rex STED microscopy for resolution of a nanometer scale (bottom). Inset, Smallest
spots resolved for confocal (right) and STED microscopy (left) determining the minimum reso-
lution of both imaging modes (4 individual clusters averaged). Note that, especially in case of
Figure 5. Antibody-induced clustering of APP increases endocytosis. A, CFP–swAPP was
labeledwith anti-GFP antibody on the cell surface in flotillin-2 knockdown (flot-2) or control
N2a (flot-2 ) cells. Cells were subsequently either clustered with a bivalent Cy3-coupled
secondary antibody or not and subjected to endocytosis for 15 min (left) or 30 min (right). To
measure the internalization of APP, the ratios of Cy3 intensity originating from the cell interior
and the total cell were determined. Ratios are shown as means SEM (n 70 cells for each
condition).B, N2a cellswere treatedwith 1mMmCD for 2 h or not before labeling CFP–swAPP
on the cell surfacewith 6E10, followedby Cy3-conjugated secondary antibody clustering or not.
Antibody uptake was performed in medium supplemented with lipoprotein-free serum for 15
and 30min. Ratios of internalized to total labeled APP are shown as means SEM. The inhib-
itory effect of cholesterol depletion on APP endocytosis can be reversed by clustering with
bivalent secondary antibody. Ratios are shown as means  SEM (n  75 cells for each
condition).
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sis (Abrami et al., 2003). For efficient endocytosis, the anthrax
toxin requires rafts to promote receptor clustering, and a recent
report suggests that clustering involves a conformational change
of the clustered receptor, which is a prerequisite for its subse-
quent ubiquitination and incorporation into clathrin-coated pits
(Abrami et al., 2006). Other examples are the tetanus neurotoxin
and the prion protein, which reside in lipid rafts fromwhich they
seem to dissociate after lateral sorting and association with the
clathrin coat (Sunyach et al., 2003; Deinhardt et al., 2006). One
might envision a similar mechanism for the endocytosis of APP.
It is possible that APP transiently interacts with flotillin-2 in a
cholesterol-dependent manner before being internalized. Addi-
tional experiments will be required to clarify the question
whether clusters of APP and flotillin are internalized together or
dissociate before entering clathrin-coated pits.
It will also be interesting to study how other APP-interacting
proteins that are known to regulate its endocytosis are connected
to this process. It was demonstrated recently that the low-density
lipoprotein receptor-related protein (LRP) promotes the associ-
ation of APP with detergent-resistant membranes (Yoon et al.,
2007). LRPmay, thus, function as an additional stabilizing factor
for the interaction of APP with cholesterol-rich membrane do-
mains, and this mechanismmay also contribute to the regulation
of APP endocytosis.
It is tempting to speculate that plasma membrane cholesterol
may promote the assembly of an APP-containing protein com-
plex involved in the uptake of cholesterol. Interestingly, the in-
ternalization of cholesterol-rich lipoprotein particles by apoE re-
ceptors also triggers the endocytosis and processing of APP (Ye et
al., 2005; He et al., 2007). The physiological relevance of this link
between cholesterol and APP internalization is not clear, but re-
cent evidence points to a role of APP processing in the regulation
of lipid homeostasis (Grimm et al., 2005). Future studies are
necessary to elucidate whether flotillin might also be involved in
the regulation of neuronal cholesterol uptake.
In summary, we propose a model in which flotillin acts as a
scaffolding protein, forming a platform for the clustering of APP
and subsequent endocytosis into a specialized clathrin-
dependent pathway. It will be interesting to investigate whether
flotillin-dependent clustering of APP also facilitates the dimer-
ization of APP, which was shown recently to result in increased
A production by a direct modulation of the gamma-secretase
complex (Munter et al., 2007).
Clearly more work is required to elucidate the molecular de-
tails of the regulation ofAPP endocytosis. Such studies areworth-
while in particular in light of the genetic association of late-onset
AD with the neuronal sortilin-related receptor, Sorl1, a protein
involved in the regulation of the endosomal trafficking of APP
(Spoelgen et al., 2006; Rogaeva et al., 2007) and the known endo-
cytic pathway abnormalities in Alzheimer’s disease (Cataldo et
al., 2003; Nixon, 2005; Laifenfeld et al., 2007).
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